Navigation Links
Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference
Date:8/7/2009

TORONTO, Aug. 7 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX:TTH) today announced that Dr. Tony Cruz, Chairman and Chief Executive Officer, will present at the upcoming Canaccord Adams 29th Annual Global Growth Conference. Dr. Cruz's presentation will take place on Wednesday, August 12, 2009 at 11:00 A.M. (Eastern Time) in Boston, MA.

    About Transition
    ----------------

Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include ELND005 (AZD-103) for the treatment of Alzheimer's disease and TT-223 for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates acquired externally and developed internally using its proprietary drug discovery engine. Transition's shares are listed on the NASDAQ under the symbol "TTHI" and the Toronto Stock Exchange under the symbol "TTH". For additional information about the Company, please visit www.transitiontherapeutics.com.

Notice to Readers: Information contained in our press releases should be considered accurate only as of the date of the release and may be superseded by more recent information we have disclosed in later press releases, filings with the OSC, SEC or otherwise. Except for historical information, this press release may contain forward-looking statements, relating to expectations, plans or prospects for Transition, including conducting clinical trials. These statements are based upon the current expectations and beliefs of Transition's management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include factors beyond Transition's control and the risk factors and other cautionary statements discussed in Transition's quarterly and annual filings with the Canadian commissions.


'/>"/>
SOURCE Transition Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardiome Announces Management Transition
2. Rush University Medical Center studies program to help older adults transition from hospital to home
3. National Practice Transition Network Launches as the Country's First Membership-Based, Commission-Free Dental Practice Transition Company
4. American Scientific Resources Announces Acting CFO Transition to Full-Time
5. Sunrise to Transition from Management of EdenCare Communities
6. Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
7. Medicare, NW Denver Partners Launch Care Transitions Project
8. Digital TV Transition Coming Soon; Update Preparedness Plans
9. Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results
10. Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2009 Financial Results on Wednesday, May 13th, at 4:30 P.M. EST
11. TouchPointCare Introduces TPC Transition Home to Help Hospitals Reduce Unplanned Readmissions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Early this week, Team Iconic at ... of Nestlé KITKAT as the first global confectionery brand sourced from 100% sustainable cocoa. ... the quality of their product, through activities that focus on better farming, better lives ...
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing series of ... Each webinar features a dynamic expert and thoughtful presentation to give attendees a ... facilities. Both events are free to attend, but registration is required. ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to ... this can leave patients with dental emergencies at risk of losing a tooth or ... dental care. , Common dental emergencies include:, , Avulsed ...
(Date:2/10/2016)... ... 10, 2016 , ... Intalere’s 2016 Executive Forum, taking place ... the country’s top healthcare executives to share insights on transformational strategies to drive ... is the provider-centric perspective, experience, expertise and strategy shared by the participants,” said ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Emmy award winner and inspirational speaker Jan Fox will serve as keynote speaker ... Boldly will provide participants with tools to more effectively communicate with their own ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... OR AKIVA, Israel , February 10, ... Ltd., a leader in the field of cartilage repair, ... on February 5, 2016. The $15 million investment was ... leading Chinese pharmaceutical manufacturer, and was joined by existing ... Financial Holdings and both the Technion Research & Development ...
(Date:2/10/2016)... New York , February 10, 2016 ... Growth, Trends and Forecast 2015 - 2023 ", reveals that ... rather slow growth from 2015 to 2023 owing to patent ... a meager CAGR of 1.30% during the forecast period, the ... to US$38.9 bn in 2023. --> Antibacterial Drugs ...
(Date:2/10/2016)... 2016  Silicon Biosystems Menarini Inc., a developer ... uncover the biological complexities of disease at the ... of innovative technologies for genomics research, today announced ... enabling translational researchers to obtain high-quality sequencing results ... and normal cells in an optimized and seamless ...
Breaking Medicine Technology: